About Community Pharmacy South Central
Continuously improving the quality of care we give patients and
improving the outcomes of their treatment is the core purpose of
the new NHS commissioning system.
The latest news
Information on training events and resources available for you and your team
Written by admin on Wednesday 18th October 2017
Certain pages on this news feed are only available to RPS members and hence requires members to log-in accordingly
Teva UK Limited trading as ratiopharm GmbH is recalling unexpired stock of Ranitidine effervescent tablets from pharmacies...
We're introducing a face-to-face forum for you to tell us how we’re doing at this year’s RPS Annual Conference. We’re calling it #RPSYourSay.
This is your chance to get your voi
The RPS in Wales has submitted proposals to the All Wales Chief Pharmacists Group around the implementation of recommendations made in our recent policy on pharmacy’s role in palliative and end
Alliance Pharmaceuticals Ltd has informed the Medicines and Healthcare products Regulatory Agency (MHRA) that there are possible side effects not reported on the Patient Information Leaflet (PIL).
Aventis Pharma Limited t/a Sanofi has informed the Medicines and Healthcare products Regulatory Agency (MHRA) that a change to the Patient Information Leaflet, concerning possible side effects for Rif
The Department of Health and Social Care (DHSC) has advised of a disruption to supply of all oral formulations of ranitidine until further notice.
RPS England Board Chair Claire Anderson comments on the highlights of the October meeting:
“Our last Board meeting of the year marked the launch of our wellbeing survey on World Mental Health D
The Department of Health and Social Care (DHSC) has issued a supply issue update on Detrusitol XL, Adrenaline Auto-Injectors and Nardil...
On World Mental Health day (10 October) we are calling for all pharmacists to have equal access toservices to support their mental health and wellbeing. As a first step in our campaignwe've launch
GlaxoSmithKline, trading as Glaxo Welcome Ltd, is recalling all unexpired stock of Zantac (ranitidine hydrochloride) prescription only medicines (POM) from pharmacies.